These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2258788

  • 1. Prostacyclin in hypertension.
    Frölich JC.
    J Hypertens Suppl; 1990 Sep; 8(4):S73-8. PubMed ID: 2258788
    [Abstract] [Full Text] [Related]

  • 2. [Prostacyclin in hypertension].
    Frölich JC.
    Z Kardiol; 1992 Jun; 81(6):303-9. PubMed ID: 1496851
    [Abstract] [Full Text] [Related]

  • 3. Short-term increase in prostaglandin I2 synthesis caused by cicletanine in patients with essential hypertension.
    Yasu T, Imanishi M, Kimura G, Tsuji T, Matsuoka H, Kuramochi M, Omae T.
    Am J Hypertens; 1995 Sep; 8(9):944-8. PubMed ID: 8541011
    [Abstract] [Full Text] [Related]

  • 4. Cicletanine stimulates cholesteryl ester hydrolase activities and prostacyclin production in arterial smooth muscle cells.
    Hajjar DP, Pomerantz KB.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():79-84. PubMed ID: 2558623
    [Abstract] [Full Text] [Related]

  • 5. Oxidant exposure stimulates cultured coronary artery endothelial cells to release 15-HETE: differential effects on PGI2 and 15-HETE synthesis.
    Callahan KS, Garcia JG.
    J Lab Clin Med; 1994 Oct; 124(4):569-78. PubMed ID: 7930881
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by aspirin of the stimulated PGI2 synthesis after administration of kallikrein to hypertensive patients (new aspects of chemical pathogeny concerning the messenger systems: A and C).
    Belloiu DD, Briese A, Tarnovschi A, Belloiu I, Tabata R, Stergiopoulos K.
    Endocrinologie; 1987 Oct; 25(2):107-13. PubMed ID: 2820018
    [Abstract] [Full Text] [Related]

  • 7. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR, Ramwell PW.
    Circ Shock; 1980 Oct; 7(3):299-308. PubMed ID: 7004660
    [Abstract] [Full Text] [Related]

  • 8. Beta adrenergic receptor stimulated prostacyclin synthesis in rabbit coronary endothelial cells is mediated by selective activation of phospholipase D: inhibition by adenosine 3'5'-cyclic monophosphate.
    Ruan Y, Kan H, Malik KU.
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1038-46. PubMed ID: 9190834
    [Abstract] [Full Text] [Related]

  • 9. [Reduction of kidney prostaglandin synthesis in patients with essential hypertension. Stimulating effect of cicletanine].
    Hornych A, Boisson J, Gaschard JC.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():85-90. PubMed ID: 2514674
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E, Lähteenmäki TA, Alanko J, Vuorinen P, Vapaatalo H.
    Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D, Currie MG, Mollace V.
    J Clin Invest; 1996 Jun 01; 97(11):2562-8. PubMed ID: 8647949
    [Abstract] [Full Text] [Related]

  • 12. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells.
    Curwen KD, Gimbrone MA, Handin RI.
    Lab Invest; 1980 Mar 01; 42(3):366-74. PubMed ID: 6244462
    [Abstract] [Full Text] [Related]

  • 13. PGI2 opens potassium channels in retinal pericytes by cyclic AMP-stimulated, cross-activation of PKG.
    Burnette JO, White RE.
    Exp Eye Res; 2006 Dec 01; 83(6):1359-65. PubMed ID: 16959250
    [Abstract] [Full Text] [Related]

  • 14. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr 01; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 15. Effects of prostacyclin on fetal platelet function.
    Matsumoto T, Kihira M, Ito M, Sugiyama Y.
    Biol Res Pregnancy Perinatol; 1984 Apr 01; 5(1):11-5. PubMed ID: 6322874
    [Abstract] [Full Text] [Related]

  • 16. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL.
    Altern Med Rev; 2006 Mar 01; 11(1):23-9. PubMed ID: 16597191
    [Abstract] [Full Text] [Related]

  • 17. [Acute hemodynamic effects of prostacyclin in severe or malignant hypertension].
    Chaignon M, Tannière-Ruffie ML, Lucsko M, Guédon J.
    Arch Mal Coeur Vaiss; 1982 Jun 01; 75 Spec No():147-50. PubMed ID: 6810818
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME, Lacasse-M S, Larivière R, Lebel M.
    Can J Physiol Pharmacol; 2005 Jun 01; 83(6):467-75. PubMed ID: 16049546
    [Abstract] [Full Text] [Related]

  • 19. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F, Corti R, Noll G, Lüscher TF.
    J Hypertens Suppl; 1999 Feb 01; 17(1):S25-35. PubMed ID: 10340841
    [Abstract] [Full Text] [Related]

  • 20. Role of kinins and prostacyclin in blood pressure regulation.
    Bönner G.
    Arch Mal Coeur Vaiss; 1989 Nov 01; 82 Spec No 4():15-9. PubMed ID: 2514656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.